Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-03-06, Stock:JNJ, The news for the past five days is as follows:
2018-02-27: NEWS1: U.S. to seek reimbursement from opioid makers, distributors.NEWS2: DOJ to support lawsuits against companies selling opioids.NEWS3: The Klein Law Firm Announces a Class Action Filed on Behalf of Johnson & Johnson Shareholders and a Lead Plaintiff Deadline of April 9, 2018 (JNJ).NEWS4: TTOO Gains Steam, LPCN Up On Upgrade, ALDX Abuzz.NEWS5: TTOO Gains Steam, LPCN Up On Upgrade, ALDX Abuzz.NEWS6: JNJ INVESTORS ALERT: Lieff Cabraser Announces Securities Class Action Against Johnson & Johnson.NEWS7: Johnson & Johnson Poised to Move Higher, Buy Available Weakness.NEWS8: JNJ’s Cardiovascular Segment’s Performance in 4Q17 and 2017.NEWS9: 3 Reasons AbbVie Inc. Stock Could Keep Soaring in 2018.NEWS10: 3 Reasons AbbVie Inc. Stock Could Keep Soaring in 2018.NEWS11: 3 Reasons AbbVie Inc. Stock Could Keep Soaring in 2018.NEWS12: How Did Johnson & Johnson’s Zytiga Perform in 2017?.NEWS13: Darzalex Could Boost JNJ’s Revenue Growth in 2018.NEWS14: [$$] Boost Biomes Launches with Seed Round for Sustainable Farming.NEWS15: Masonite adds health care, tech industry veterans to board of directors.NEWS16: Why Achillion Pharmaceuticals, Inc. Stock Spiked Today.NEWS17: Why Achillion Pharmaceuticals, Inc. Stock Spiked Today.
2018-02-28: NEWS1: Cramer's lightning round: Nokia has become a good spec. I'm done selling.NEWS2: MedTech&apos;s Long-Term Prospects Outweigh Near-Term Risks.NEWS3: J&J Shares Off to Worst Start to a Year This Century: RBC Capital Markets.NEWS4: Noteworthy ETF Inflows: IVV, JPM, JNJ, GOOG.NEWS5: Noteworthy ETF Inflows: IVV, JPM, JNJ, GOOG.NEWS6: The Klein Law Firm Notifies Investors of a Class Action Filed on Behalf of Johnson & Johnson Shareholders and a Lead Plaintiff Deadline of April 9, 2018.NEWS7: Zacks Industry Outlook Highlights: Johnson & Johnson, Medtronic, Covidien and Smith & Nephew, Abbott Labs and Boston Scientific.NEWS8: Zacks Industry Outlook Highlights: Johnson & Johnson, Medtronic, Covidien and Smith & Nephew, Abbott Labs and Boston Scientific.NEWS9: Theravance Biopharma (TBPH) Q4 Loss Wider, Sales Drop Y/Y.NEWS10: Theravance Biopharma (TBPH) Q4 Loss Wider, Sales Drop Y/Y.NEWS11: SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Johnson & Johnson (JNJ) & Lead Plaintiff Deadline - April 9, 2018.NEWS12: Theravance Biopharma (TBPH) Q4 Loss Wider, Sales Drop Y/Y.NEWS13: Perrigo Company (PRGO) Ex-Dividend Date Scheduled for March 01, 2018.NEWS14: Perrigo Company (PRGO) Ex-Dividend Date Scheduled for March 01, 2018.NEWS15: Zacks Industry Outlook Highlights: Johnson & Johnson, Medtronic, Covidien and Smith & Nephew, Abbott Labs and Boston Scientific.NEWS16: Analysts’ Recommendations for Johnson & Johnson in February 2018.NEWS17: Medical Device Industry Outlook - February 2018.NEWS18: Medical Device Industry Outlook - February 2018.NEWS19: 3 Dividend Stocks That Are Minting Money.NEWS20: 3 Dividend Stocks That Are Minting Money.NEWS21: 3 Dividend Stocks That Are Minting Money.NEWS22: 10 Best Stocks to Buy and Hold Forever.NEWS23: 10 Best Stocks to Buy and Hold Forever.
2018-03-01: NEWS1: How Tax Cuts and Jobs Act Impacted Align’s 4Q17 Earnings.NEWS2: Making Sense of Twitter’s Audience Metrics.NEWS3: Jim Cramer Advises His Viewers On Johnson & Johnson, Nokia And More.NEWS4: Cramer's lightning round: Nokia has become a good spec. I....
2018-03-02: NEWS1: Johnson & Johnson to Pay Dividend of $0.84 on March 13.NEWS2: Wall Street More Optimistic about Johnson & Johnson after 4Q17.NEWS3: IMPORTANT SHAREHOLDER NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Johnson & Johnson And Encourages Investors To Contact The Firm.NEWS4: Johnson & Johnson Advances in Robotics Surgery with Orthotaxy.NEWS5: Boston Scientific: Analysts’ Ratings in February 2018.NEWS6: Like Google, Baidu Is Battling an Online Video Problem.NEWS7: Why M&A Could Be Even More Lucrative Amid Market Volatility -- ICYMI.
2018-03-05: NEWS1: Senator Asks Drug Companies What They'll Do With Extra Cash From Big Tax Cut.NEWS2: The Klein Law Firm Notifies Investors of a Class Action Filed on Behalf of Johnson & Johnson Shareholders and a Lead Plaintiff Deadline of April 9, 2018.NEWS3: Stryker’s Ischemic Stroke Market Expands on FDA Update.NEWS4: EQUITY NOTICE: Rosen Law Firm Files Securities Class Action Lawsuit Against Johnson & Johnson – JNJ.NEWS5: 5 Dividend Aristocrats Where Analysts See Capital Gains.NEWS6: 5 Dividend Aristocrats Where Analysts See Capital Gains.NEWS7: Here's My Top Stock to Buy in March.NEWS8: Here's My Top Stock to Buy in March.NEWS9: Phibro Animal Health Corporation (PAHC) Ex-Dividend Date Scheduled for March 06, 2018.NEWS10: Phibro Animal Health Corporation (PAHC) Ex-Dividend Date Scheduled for March 06, 2018.NEWS11: Johnson & Johnson’s Acclarent Aera Balloon Dilation System.NEWS12: Johnson & Johnson Stock: What’s behind the Recent Decline?.NEWS13: Sanofi Pasteur’s 4Q17 Performance.NEWS14: New Drugs Approved In February.NEWS15: New Drugs Approved In February.

Answer: Decrease